Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by SOTIO Biotech
SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline
July 16, 2024
From
SOTIO Biotech
Via
Business Wire
SOTIO Announces First Patient Dosed in Phase 1 Clinical Study of SOT201 for Patients with Solid Tumors
May 28, 2024
From
SOTIO Biotech
Via
Business Wire
SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
May 23, 2024
From
SOTIO Biotech
Via
Business Wire
SOTIO to Present Poster on DUET-01 Clinical Trial at 2024 ASCO Annual Meeting
April 24, 2024
From
SOTIO Biotech
Via
Business Wire
SOTIO Presents New Preclinical Data on Enhanced CAR T-Cell Therapies at AACR Annual Meeting
March 12, 2024
From
SOTIO Biotech
Via
Business Wire
SOTIO Presents Data on SOT201 Immunocytokine and Other Programs at SITC Annual Meeting
October 31, 2023
From
SOTIO Biotech
Via
Business Wire
SOTIO Further Expands Next-Generation ADC Platform with License to Synaffix’s ADC Technology
October 16, 2023
From
SOTIO Biotech
Via
Business Wire
SOTIO Provides Update on Interim Data from Clinical Trials of Nanrilkefusp Alfa
October 13, 2023
From
SOTIO Biotech
Via
Business Wire
SOTIO Announces First Patients Dosed in Two Combination Arms of CLAUDIO-01 Study Evaluating SOT102 in First-Line Gastric and Pancreatic Cancer
October 11, 2023
From
SOTIO Biotech
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.